A genetic variant controls interferon-β gene expression in human myeloid cells by preventing C/EBP-β binding on a conserved enhancer.
Interferon β (IFN-β) is a cytokine that induces a global antiviral proteome, and regulates the adaptive immune response to infections and tumors. Its effects strongly depend on its level and timing of expression. Therefore, the transcription of its coding gene IFNB1 is strictly controlled. We have p...
Main Authors: | Anaïs Assouvie, Maxime Rotival, Juliette Hamroune, Didier Busso, Paul-Henri Romeo, Lluis Quintana-Murci, Germain Rousselet |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-11-01
|
Series: | PLoS Genetics |
Online Access: | https://doi.org/10.1371/journal.pgen.1009090 |
Similar Items
-
Functional consequences of archaic introgression and their impact on fitness
by: Maxime Rotival, et al.
Published: (2020-01-01) -
The C/EBPβ LIP isoform rescues loss of C/EBPβ function in the mouse
by: Valérie Bégay, et al.
Published: (2018-05-01) -
Defining the genetic and evolutionary architecture of alternative splicing in response to infection
by: Maxime Rotival, et al.
Published: (2019-04-01) -
In vivo deficiency of both C/EBPβ and C/EBPε results in highly defective myeloid differentiation and lack of cytokine response.
by: Tadayuki Akagi, et al.
Published: (2010-11-01) -
Lymphoid to myeloid cell trans-differentiation is determined by C/EBPβ structure and post-translational modifications.
by: Bilyana Stoilova, et al.
Published: (2013-01-01)